News Chart Emmaus Life Sciences, Inc.

Equities

EMMA

US29137T1016

Delayed OTC Markets Other stock markets 03:23:12 2024-07-08 pm EDT			5-day change	1st Jan Change
0.0752 ^USD	-5.87%		-17.72%	-24.88%

Jul. 03	Emmaus Life Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 02	Emmaus Life Sciences, Inc. Receives Marketing Authorization from the Puerto Rico Department of Health for Endari® (L-Glutamine Oral Powder)	CI

0f27c486c7560dabc3a.EviQPRSYkaOo84GRObFocZXD3gKRcsOZP4C0n4-Bjk4.Xq3DRGH99sbqqcjwQ4cSK6G2pmHLRYeuXOv_-MvowT9im-JWXu7QzOucxA~7894b7d8ed6c54e90ffb4f549835f96d